导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 3.48% | 41/2963 |
| 近一周 | 0.05% | 359/3224 |
| 近一月 | -0.01% | 935/3228 |
| 近一季 | 0.93% | 79/3199 |
| 近半年 | 1.15% | 170/3119 |
| 近一年 | 4.06% | 29/2926 |
| 近两年 | 7.50% | 358/2419 |
| 近三年 | 8.83% | 1382/2057 |
| 成立以来 | 276.25% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
0.54% 121/3040 |
1.91% 108/3451 |
-0.20% 1413/3498 |
- - |
| 2024 | 3.67% 2156/3316 |
0.69% 2707/3226 |
1.12% 1803/3360 |
-0.43% 2998/3195 |
2.27% 886/3316 |
| 2023 | 1.30% 2637/3108 |
0.32% 2551/2776 |
0.32% 2700/2849 |
0.14% 2669/2940 |
0.51% 2693/3108 |
| 2022 | 1.39% 2028/2726 |
0.38% 1525/1949 |
0.28% 1879/2522 |
0.49% 2275/2598 |
0.24% 428/2732 |
| 2021 | 63.85% 2/2409 |
-0.14% 1922/2068 |
0.54% 1868/2668 |
62.55% 3/2731 |
0.40% 2162/2416 |
| 2020 | 1.50% 1517/2196 |
1.50% 1225/1576 |
-0.70% 1366/2274 |
0.10% 862/2475 |
0.61% 1902/2563 |
| 2019 | 3.29% 1033/1720 |
1.00% 1171/1682 |
0.62% 781/1825 |
1.06% 942/1762 |
0.58% 1599/1956 |
| 2018 | 104.32% 1/1267 |
- - |
97.76% 2/1345 |
0.02% 1145/1404 |
1.27% 780/1542 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 易方达标普生物科技美元汇A | 0.2432 | 29.46% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 汇安行业龙头混合A | 2.4323 | 22.37% |
| 华商致远回报混合A | 1.6762 | 21.58% |
| 广发生物科技指数美元(QDII)C | 0.2047 | 18.46% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇 | 1.3424 | 17.84% |
| 华夏上证科创板半导体材料设备主题ETF联接C | 1.2373 | 17.83% |
| 宝盈国家安全沪港深股票C | 2.1469 | 17.42% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币A | 1.3726 | 17.14% |
| 广发上海金ETF | 9.7032 | 16.81% |
| 金信民兴债券A VS. () |